Cargando…
Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence
OBJECTIVE: To examine the relative impact of three management options in patients aged <60 years with cryptogenic stroke and a patent foramen ovale (PFO): PFO closure plus antiplatelet therapy, antiplatelet therapy alone and anticoagulation alone. DESIGN: Systematic review and network meta-analys...
Autores principales: | Mir, Hassan, Siemieniuk, Reed Alexander C, Ge, Long Cruz, Foroutan, Farid, Fralick, Michael, Syed, Talha, Lopes, Luciane Cruz, Kuijpers, Ton, Mas, Jean-Louis, Vandvik, Per O, Agoritsas, Thomas, Guyatt, Gordon H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067350/ https://www.ncbi.nlm.nih.gov/pubmed/30049703 http://dx.doi.org/10.1136/bmjopen-2018-023761 |
Ejemplares similares
-
Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline
por: Kuijpers, Ton, et al.
Publicado: (2018) -
Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management
por: Lucà, Fabiana, et al.
Publicado: (2023) -
Correction: Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence
Publicado: (2018) -
Evaluation of Patent Foramen Ovale in Young Adults with Cryptogenic Stroke
por: Ali Ebrahimi, Hossein, et al.
Publicado: (2011) -
Cryptogenic Stroke: To Close a Patent Foramen Ovale or Not to
Close?
por: Kottoor, Santhosh J, et al.
Publicado: (2018)